758 related articles for article (PubMed ID: 26994844)
21. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
Srinivasan B; Tonddast-Navaei S; Skolnick J
Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
[TBL] [Abstract][Full Text] [Related]
22. 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.
Yang X; Wedajo W; Yamada Y; Dahlroth SL; Neo JJ; Dick T; Chui WK
Eur J Med Chem; 2018 Jan; 144():262-276. PubMed ID: 29274493
[TBL] [Abstract][Full Text] [Related]
23. Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
Tonelli M; Naesens L; Gazzarrini S; Santucci M; Cichero E; Tasso B; Moroni A; Costi MP; Loddo R
Eur J Med Chem; 2017 Jul; 135():467-478. PubMed ID: 28477572
[TBL] [Abstract][Full Text] [Related]
24. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
Singh P; Kaur M; Sachdeva S
J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
[TBL] [Abstract][Full Text] [Related]
25. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
[TBL] [Abstract][Full Text] [Related]
26. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
[TBL] [Abstract][Full Text] [Related]
27. Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage.
Wang X; Qian J; Zhu P; Hua R; Liu J; Hang J; Meng C; Shan W; Miao J; Ling Y
ChemMedChem; 2021 Feb; 16(4):702-712. PubMed ID: 33085980
[TBL] [Abstract][Full Text] [Related]
28. Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.
Zhang Z; Tian C; Zhou S; Wang W; Guo Y; Xia J; Liu Z; Wang B; Wang X; Golding BT; Griff RJ; Du Y; Liu J
Eur J Med Chem; 2012 Dec; 58():228-36. PubMed ID: 23124219
[TBL] [Abstract][Full Text] [Related]
29. Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study.
Abdelaziz OA; El Husseiny WM; Selim KB; Eisa HM
Bioorg Chem; 2019 Sep; 90():103076. PubMed ID: 31260878
[TBL] [Abstract][Full Text] [Related]
30. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
31. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
32. Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
Ozgencli I; Budak H; Ciftci M; Anar M
Anticancer Agents Med Chem; 2018; 18(11):1599-1605. PubMed ID: 29793415
[TBL] [Abstract][Full Text] [Related]
33. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Antimicrobial Evaluation and Molecular Docking of Some Potential 2,6-disubstituted 1H-Benzimidazoles; Non-Classical Antifolates.
Harer S; Bhatia M; Kawade V
Med Chem; 2019; 15(7):813-832. PubMed ID: 30727904
[TBL] [Abstract][Full Text] [Related]
36. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
[TBL] [Abstract][Full Text] [Related]
37. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor.
Sahu S; Ghosh SK; Gahtori P; Pratap Singh U; Bhattacharyya DR; Bhat HR
Pharmacol Rep; 2019 Oct; 71(5):762-767. PubMed ID: 31351317
[TBL] [Abstract][Full Text] [Related]
38. Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase.
Krasavin M; Žalubovskis R; Grandāne A; Domračeva I; Zhmurov P; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):506-510. PubMed ID: 31928252
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
Wang Y; Zhang W; Dong J; Gao J
Bioorg Chem; 2020 Jan; 95():103530. PubMed ID: 31887477
[TBL] [Abstract][Full Text] [Related]
40. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
Cheng Y; Qi Y
Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
